Refractive outcomes following unilateral laser treatment for type 1 retinopathy of prematurity

被引:0
|
作者
Bayramoglu, Sadik Etka [1 ,3 ]
Sayin, Nihat [1 ]
Ekinci, Dilbade Yildiz [2 ]
机构
[1] Univ Hlth Sci, Kanuni Sultan Suleyman Training & Res Hosp, Dept Ophthalmol, Istanbul, Turkey
[2] Univ Hlth Sci, Diyarbakir Training & Res Hosp, Dept Ophthalmol, Diyarbakir, Turkey
[3] Kanuni Sultan Suleyman Egitim & Aras Tirma Hastane, Goz Klin, Sadik Etka Bayramoglu, Atakent Mah Turgut Ozal Bulvari, Istanbul, Turkey
来源
JOURNAL OF AAPOS | 2022年 / 26卷 / 05期
关键词
INTRAVITREAL BEVACIZUMAB; INFANTS; MYOPIA; LESS; PHOTOCOAGULATION;
D O I
10.1016/j.jaapos.2022.07.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE To compare refractive outcomes of infants with type 1 retinopathy of prematurity (ROP) in whom one eye was treated with laser and the fellow eye spontaneously regressed.METHODS The medical records of infants who underwent IVB and laser treatment for type 1 ROP or aggressive posterior-ROP between January 2016 and December 2019 were retrospectively evaluated. Infants in whom ROP in the fellow eye regressed and for whom refractive data was available in the record were included in the study. Refractive outcomes of unilaterally treated infants were assessed.RESULTS A total of 283 cases were reviewed: of these, 17 experienced spontaneous regression in the fellow eye and were included. All unilateral laser-treated eyes had type 1 ROP in zone II. The median age at treatment was 40 weeks' postmenstrual age (IQR, 39-41). The mean spherical equivalent at the last examination was 2.1 +/- 2.5 D in treated eyes and 2.50 +/- 1.4 D in nontreated eyes, at a mean age of 25.0 +/- 9.1 months (P = 0.378). Of the 7 infants who underwent fluorescein angiography, the median of the ratio of the length of the temporal retinal vascularization to the optic disk-to-fovea distance was 3.71 (3.22-3.79) in treated and 4.28 (3.90-4.49) in untreated eyes, at a median age of 18 months (P = 0.018).CONCLUSIONS In laser-treated eyes with peripheral zone II ROP and with advanced treatment age, we did not observe a significant myopic change compared to the fellow untreated eye. ( J AAPOS 2022;26:245.e1-6)
引用
收藏
页码:245.e1 / 245.e6
页数:6
相关论文
共 50 条
  • [1] Diode laser treatment of retinopathy of prematurity - Anatomical and refractive outcomes
    Axer-Siegel, Ruth
    Maharshak, Idit
    Snir, Moshe
    Friling, Ronit
    Ehrlich, Rita
    Sherf, Ilana
    Shalev, Benjamin
    Sirota, Lea
    Weinberger, Dov
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (06): : 839 - 846
  • [2] Structural and refractive outcomes of intravitreal ranibizumab followed by laser photocoagulation for type 1 retinopathy of prematurity
    Hoppe, Charis
    Holt, Derick G.
    Arnold, Benjamin F.
    Thinda, Sumeer
    Padmanabhan, Sriranjani P.
    Oatts, Julius T.
    [J]. JOURNAL OF AAPOS, 2022, 26 (06): : 305.e1 - 305.e6
  • [3] Cryotherapy and laser treatment for acute retinopathy of prematurity: Refractive outcomes, a longitudinal study
    Laws, F
    Laws, D
    Clark, D
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (01) : 12 - 15
  • [4] Evaluation of refractive outcomes and ophthalmic parameters after laser treatment for retinopathy of prematurity
    Aoyama, Yurika
    Kure, Kana
    Tsuneyoshi, Saori
    Yamamoto, Risako
    Sugiura, Aya
    Asaoka, Ryo
    Obata, Ryo
    Inoue, Tatsuya
    Aihara, Makoto
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Refractive outcome following unilateral retinopexy in infants with asymmetric retinopathy of prematurity
    Segal, WA
    Sternberg, P
    Capone, A
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 604 - 604
  • [6] Transscleral vs transpupillary diode laser photocoagulation for the treatment of zone II type 1 retinopathy of prematurity: Anatomical and refractive outcomes
    Roohipourmoallai, Ramak
    Faghihi, Shahin
    Faghihi, Hooshang
    Torkashvand, Ali
    Nabavi, Amin
    Fooladi, Marjan, I
    Farahani, Afsar D.
    Bazvand, Fatemeh
    Iyer, Siva S. R.
    Ebrahimiadib, Nazanin
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (01) : 189 - 193
  • [7] Outcomes following treatment of type 1retinopathy of prematurity with bevacizumab versus laser: two year follow up
    Isaac, Maram
    Mireskandari, Kamiar
    Tehrani, Nasrin Najm
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity
    McLoone, Eibhlin M.
    O'Keefe, Michael
    McLoone, Sean F.
    Lanigan, Bernadette M.
    [J]. JOURNAL OF AAPOS, 2006, 10 (05): : 454 - 459
  • [9] Binocularity outcomes following treatment for retinopathy of prematurity
    Manuchian, Sonia
    Mireskandari, Kamiar
    Tehrani, Nasrin N.
    Isaac, Maram
    Robitaille, Johane M.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (03): : 179 - 183
  • [10] Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser
    Isaac, Maram
    Mireskandari, Kamiar
    Tehrani, Nasrin
    [J]. JOURNAL OF AAPOS, 2015, 19 (02): : 140 - 144